AnaptysBio (MEX:ANAB) FFO


MEX:ANAB AnaptysBio Inc MEX:ANAB
67 GF Score
Price MXN445.25
GF Value MXN461.00
! 3 Warning Signs
View Full Analysis

What is AnaptysBio FFO?

FFO (Funds from operations) only applies to REITs.

MEX:ANAB
67GF Score
AnaptysBio Inc MEX:ANAB
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AnaptysBio (MEX:ANAB) Overvalued in 2026?

Based on GuruFocus' analysis, AnaptysBio stock appears to be undervalued. The current stock price of MXN445.25 is trading 3.4% below its estimated GF Value™ of MXN461.00.

Key valuation signals for MEX:ANAB:

  • FFO:
  • GF Value™: MXN461.00 vs. price of MXN445.25 (3.4% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the MEX:ANAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AnaptysBio Business Description

Other Exchanges ANAB:USA0HFQ:UKAN6:Germany
Address 10770 Wateridge Circle, Suite 210, San Diego, CA, USA, 92121
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).
67GF Score

Get the complete analysis for MEX:ANAB

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN445.25
Price
MXN461.00
GF Value